Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Aerogen announced today that it plans to invest about $308.5 million (€300 million) to expand operations in Ireland.

Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 ...

BD (NYSE:BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...

Spirit Health said on social media that it plans to make a new continuous glucose monitor (CGM) available next month.

Acton, Massachusetts-based Insulet touts Omnipod 5 as the number one insulin pump for new users in Europe. It remains the top ...

CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology.

Dexcom (Nasdaq:DXCM) today announced preliminary financial results with projections for significant sales growth in 2025.

Dexcom (Nasdaq:DXCM) announced that it entered into a new partnership with Life Time Inc., an operator of athletic country clubs.

Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split.